Prellis Biologics logo

Prellis Biologics

Prellis Biologics is developing technology to build transplantable human organs and tissues.

6

Funding Rounds

$88.0m

Money raised

Overview

Prellis Biologics is developing technology to build transplantable human organs and tissues.
Name Email Phone Social networks
Me***** Ma****
  • *******@prellisbio.com
- linkedin twitter
No**** Mu**** - - linkedin twitter facebook

Funding

Funding series

Funding Series Analysis

The company Prellis Biologics has raised a total of $58.2m in funding over 6 rounds.

Key Insights:

  • Prellis Biologics Series C round, August 10, 2022: $35m
  • Prellis Biologics Series B round, December 2021: $14.5m
  • Prellis Biologics Series A round, July 2019: $8.7m
  • Prellis Biologics funding round, September 2017: $1.8m
  • Prellis Biologics funding round, August 2019: $8.7m
  • Prellis Biologics, Inc funding round, July 2021: $19.25m
Prellis Biologics logo
Prellis Biologics Series C round, August 10, 2022 $35m
Prellis Biologics logo
Prellis Biologics Series B round, December 2021 $14.5m
Prellis Biologics logo
Prellis Biologics Series A round, July 2019 $8.7m
Prellis Biologics logo
Prellis Biologics funding round, September 2017 $1.8m
Prellis Biologics logo
Prellis Biologics funding round, August 2019 $8.7m
Prellis Biologics logo
Prellis Biologics, Inc funding round, July 2021 $19.25m